National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study

Circulation

Volumn 110, Issue 10, 2004, Pages 1251-1257

  Hunt, Kelly J ^a   Resendez, Roy G ^a   Williams, Ken ^a   Haffner, Steve M ^a   Stern, Michael P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Epidemiology; Mortality; Risk factors

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADULT; ALBUMINURIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MEXICAN AMERICANS; MIDDLE AGED; MORTALITY; NATIONAL HEALTH PROGRAMS; OBESITY; PATIENT EDUCATION; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; TERMINOLOGY; TEXAS; WORLD HEALTH ORGANIZATION;

EID: 4444329030     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000140762.04598.F9     Document Type: Article

References (18)

1. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Report of a WHO Consultation. In: Alwan A, King H, eds. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1 : Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance; 1999:1-59.
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
5. Onat A, Ceyhan K, Basar O, et al. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285-292.
6. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
7. Hazuda HP, Comeaux PJ, Stern MP, et al. A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol. 1986;123:96-112.
8. Mitchell BD, Hazuda HP, Haffner SM, et al. Myocardial infarction in Mexican-Americans and non-Hispanic whites: the San Antonio Heart Study. Circulation. 1991;83:45-51.
9. Stern MP, Rosenthal M, Haffner SM, et al. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol. 1984;120:834-851.
10. Haffner SM, Stern MP, Hazuda HP, et al. The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins. Am J Epidemiol. 1986;123:830-839.
11. Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1982.
12. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979;241:2035-2038.
13. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
14. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-1214.
15. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res. 2003;11:1480-1487.
16. Haffner SM, Miettinen H, Stern MP. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia. 1997;40:711-717.
17. Hanley AJ, Wagenknecht LE, D'Agostino RB Jr, et al. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003;52:2740-2747.
18. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-443.